A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...

Breast cancer patients have been given fresh hope after a new vaccine showed “promise” in treating an aggressive form of the ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

and triple negative breast cancer (TNBC) anticipated in late 2024 and 1H 2025, respectively, by ImmuneOnco in China U.S. clinical study of SYN-2510/IMM2510 in NSCLC initiation targeted for 2H 2025 ...

We also are finalizing plans to begin the expansion portion of our trial, with an initial focus on patients with triple-negative breast cancer who have previously been treated with at least one ...

Researchers reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected 'second jobs' within the nucleus, orchestrating critical ...

In February 2022, she was diagnosed with triple-negative breast cancer. “I was shocked. I can't see only word I could just ...

An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Studies suggest the cell is more interconnected than previously thought, opening up "exciting possibilities for science and medicine." ...